Mitroflow Aortic Pericardial Heart Valves and related accessories according to the attached list ישראל - עברית - Ministry of Health

mitroflow aortic pericardial heart valves and related accessories according to the attached list

קיור מדיקל אנד טכניקל סופלאי - רופא - the valves are intended for the replacement of malfunctioning intracardiac valves.

Freka Mix range - according to attached list ישראל - עברית - Ministry of Health

freka mix range - according to attached list

קיור מדיקל אנד טכניקל סופלאי - אחות - שקיות סטריליות חד פעמיות להזנה תוך ורידית

ARTUS - In Vitro Diagnostics kits according to attached list ישראל - עברית - Ministry of Health

artus - in vitro diagnostics kits according to attached list

אלדן ציוד אלקטרוני בע"מ - צוות טכני - in vitro diagnostic kits for the detection and quantification of viral/bacterial dna/or rna

Smart Canula-access to vascular system for cardio-pulmonary bypass and circulation ישראל - עברית - Ministry of Health

smart canula-access to vascular system for cardio-pulmonary bypass and circulation

י.גיל מדיקל בע"מ - מומחה - קנולות עורקיות וורידיות לניתוחי לב חזה

פנטקסים ישראל - עברית - Ministry of Health

פנטקסים

sanofi israel ltd - conjugated to tetanus protein; diphtheria toxoid; filamentous haemagglutinin (fha); haemophilus influenzae type b polysaccharide; pertussis toxoid (pt); polio type i (mohoney); polio type ii ( m.e.f.1); polio type iii (saukett); tetanus toxoid - אבקה ותרחיף להכנת תרחיף להזרקה - polio type iii (saukett) 32 du / 0.5 ml; polio type ii ( m.e.f.1) 8 du / 0.5 ml; polio type i (mohoney) 40 du / 0.5 ml; filamentous haemagglutinin (fha) 25 mcg / 0.5 ml; pertussis toxoid (pt) 25 mcg / 0.5 ml; tetanus toxoid 40 iu / 0.5 ml; diphtheria toxoid 30 iu / 0.5 ml; haemophilus influenzae type b polysaccharide 10 mcg / 0.5 ml; conjugated to tetanus protein 18-30 mcg / 0.5 ml - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus

טרג'נטה ישראל - עברית - Ministry of Health

טרג'נטה

boehringer ingelheim israel ltd. - linagliptin - טבליות מצופות פילם - linagliptin 5 mg - linagliptin - linagliptin - as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus

פלולן אפופרוסטנול 1500 מקג לעירוי ישראל - עברית - Ministry of Health

פלולן אפופרוסטנול 1500 מקג לעירוי

glaxo smith kline (israel) ltd - epoprostenol as sodium - אבקה להכנת תמיסה לאינפוזיה - epoprostenol as sodium 1.5 mg/vial - epoprostenol - epoprostenol - flolan is indicated for the long-term intravenous treatment of primary arterial pulmonary hypertension and arterial pulmonary hypertension associated with the scleroderma spectrum of disease in nyha class iii and class iv patients who do not respond to conventional therapy.

פלולן אפופרוסטנול 500 מקג לעירוי ישראל - עברית - Ministry of Health

פלולן אפופרוסטנול 500 מקג לעירוי

glaxo smith kline (israel) ltd - epoprostenol as sodium - אבקה להכנת תמיסה לאינפוזיה - epoprostenol as sodium 0.5 mg/vial - epoprostenol - epoprostenol - flolan is indicated for the long-term intravenous treatment of primary pulmonary hypertension and pulmonary hypertension associated with the scleroderma spectrum of disease in nyha class iii and class iv patients who do not respond to conventional therapy.

אריקסטרה 2.5 מג    0.5 מל ישראל - עברית - Ministry of Health

אריקסטרה 2.5 מג 0.5 מל

padagis israel agencies ltd, israel - fondaparinux sodium - תמיסה להזרקה - fondaparinux sodium 5 mg / 1 ml - fondaparinux - fondaparinux - prevention of venous thromboembolic events (vte) in adults undergoing major orthopaedic surgery of the lower limbs such as hip fracture major knee surgery or hip replacement surgery. prevention of venous thromboembolic events (vte) in adults undergoing abdominal surgery who are judged to be at high risk of thromboembolic complications such as patients undergoing abdominal cancer surgery. prevention of venous thromboembolic events (vte) in adults medical patients who are judged to be at high risk for vte and who are immobilised due to acute illness such as cardiac insufficiency and/or acute respiratory disorders and/or acute infectious or inflammatory disease. treatment of unstable angina or non-st segment elevation myocardial infarcton (ua/nstemi) in adults for whom urgent ( < 120 mins) invasive management (pci) is not indicated . treatment of st segment elevation myocardial infarction (stemi) in patients who are managed with thrombolytics or who initially are to receive no other form of reperfusion therapy.